Clinical research, pharmaceutical development, and translational science solutions.
At Liveo Research Swiss II AG, we are committed to conducting world-class clinical trials, pharmaceutical development, and translational research that bridges laboratory discovery with patient benefit. Our integrated approach combines scientific rigor with operational excellence.
We partner with pharmaceutical companies, biotech firms, academic institutions, and healthcare organizations to accelerate drug development, validate therapeutic concepts, and bring breakthrough treatments to patients in need.
Switzerland's center for pharmaceutical innovation and clinical excellence.
Liveo Research Swiss II AG delivers comprehensive solutions across the entire pharmaceutical development continuum, from early-stage research through post-marketing surveillance. We combine scientific expertise, regulatory knowledge, and operational sophistication to manage complex clinical programs.
End-to-end management of Phase I, II, III, and IV clinical trials. We handle protocol development, site selection and management, patient recruitment, data collection, quality assurance, and regulatory submissions with uncompromising attention to patient safety and data integrity.
Comprehensive adverse event monitoring, safety reporting, and risk management systems. Our pharmacovigilance experts ensure regulatory compliance while systematically identifying and mitigating safety signals to protect patient populations worldwide.
Strategic guidance on clinical development pathways, regulatory strategy, and market access. Our consultants bring deep expertise in FDA, EMA, and other regulatory frameworks to optimize development timelines and increase approval likelihood.
Evidence generation from electronic health records, claims databases, and patient registries. We help you understand drug performance in real-world settings, support health economic analyses, and build compelling evidence for payers and clinicians.
We believe that rigorous science, operational excellence, and patient-centric values are not in tension—they are interdependent. Every clinical program we undertake is guided by these core principles.
Meticulous study design, quality data collection, and transparent analysis ensure results you can trust and defend before regulatory authorities and scientific peers.
Patient welfare is paramount. We implement robust safety monitoring, transparent informed consent processes, and protocols that prioritize participant well-being above all else.
Our team maintains expert knowledge of evolving regulatory requirements globally. We navigate complex approval pathways with precision, helping you achieve your commercial objectives efficiently.
Modern data systems, automated workflows, and lean processes allow us to conduct studies faster and more cost-effectively without compromising quality or integrity.
We maintain open communication, provide regular progress updates, and collaborate actively with your team. You remain in control of strategic decisions while leveraging our specialized expertise.
With networks across Europe, North America, and beyond, we can execute multi-country trials, access diverse patient populations, and navigate different healthcare ecosystems.
Our commitment to these principles has allowed us to successfully manage hundreds of clinical studies across multiple therapeutic areas including oncology, cardiovascular disease, infectious disease, respiratory disorders, and rare diseases. We have maintained an exemplary regulatory record, with consistent praise from sponsors, regulatory agencies, and ethics review bodies.
Whether you are a large pharmaceutical company conducting Phase III pivotal trials or a smaller biotech firm conducting investigator-sponsored research, Liveo Research Swiss II AG offers the expertise, infrastructure, and cultural alignment to make your program successful.
We have deep, specialized experience across multiple therapeutic domains and study populations. This expertise allows us to anticipate and solve challenges that emerge in complex clinical programs.
⚕️ Our therapeutic focus areas include Oncology • Hematology • Immunology • Gastroenterology • Respiratory • Cardiology • Endocrinology • Neurology • Infectious Disease • Rare & Genetic Disorders
We excel at designing and executing challenging studies including adaptive designs, basket trials, N-of-1 designs, and real-world evidence protocols. Our biostatisticians and trial design experts help you maximize information from every patient enrolled.
Experience managing studies in vulnerable and complex populations including pediatric patients, geriatric subjects, those with comorbidities, and patients from resourced-limited settings. We ensure inclusive access while protecting vulnerable study participants.
Technology Infrastructure: Our clinical trial management systems, electronic data capture (EDC) platforms, and randomization/trial supply management (RTSM) systems are state-of-the-art. We leverage data science and analytics tools to provide real-time visibility into trial progress, early safety signal detection, and predictive insights.
Quality Management: ISO 14155 accreditation and adherence to ICH-GCP E6(R2) guidelines ensure that every aspect of our work meets international quality standards. Regular internal audits, external assessments, and continuous improvement initiatives maintain our commitment to excellence.
We would welcome a conversation about your clinical research needs. Whether you are evaluating CRO partners or seeking consultation on a specific program, our team is ready to discuss how we can contribute to your success.
Contact our business development team or reach out directly to discuss a potential partnership. We typically respond to inquiries within 24 hours.
Email: partnerships@liveo-research.ch
Clinical Operations: clinical@liveo-research.ch
Business Development: business@liveo-research.ch
Phone: +41 (0) 61 XXX XXXX
Hochbergerstrasse 60B
4057 Basel
Switzerland
Hours:
Monday—Friday
08:00—18:00 CET